hip arthritis
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Patients with hip arthritis confirmed by X-ray examination; 2. Provision of complete data, including age, sex, body mass index, adverse reactions, related blood test results (platelet-related parameters and lymphocyte counts); 3. Provision of written informed consent.
Exclusion criteria
Exclusion criteria: 1. Other joint diseases, such as rheumatoid arthritis and ankylosing spondylitis; 2. Infections occurring in other regions; 3. Tumors; 4. A previous history of blood diseases.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Platelet-to-lymphocyte ratio (PLR); | — |
Secondary
| Measure | Time frame |
|---|---|
| Platelet counts;Lymphocyte counts;X-ray morphology of the hip joint;Logistic regression analysis of the risk factors for aggravating hip arthritis;Area under the ROC curve of PLR in the prediction of the severity of hip arthritis;Cut-off value of PLR in the prediction of severity of hip arthritis;Sensitivity of PLR in the prediction of severity of hip arthritis;Specificity of PLR in the prediction of severity of hip arthritis; | — |
Countries
China
Contacts
Yantai Affiliated Hospital of Binzhou Medical University